Safety and efficacy of intranasal ketamine in a mixed population with chronic pain

Pain. 2004 Aug;110(3):762-764. doi: 10.1016/j.pain.2004.04.014.

Authors

Daniel B Carr¹, Leonidas C Goudas, William T Denman, Daniel Brookoff, Philip T Lavin, Peter S Staats

Affiliation

¹ Department of Anesthesia, Box 298, Tufts-New England Medical Center, 750 Washington Street, Boston, MA 02111, USA Methodist Comprehensive Pain Institute, Methodist Hospital, Memphis, TN 38104, USA Averion, Inc., 4 California Avenue, Framingham, MA 01701, USA Johns Hopkins Hospital, Baltimore, MD 21205, USA.

PMID: 15288418
DOI: 10.1016/j.pain.2004.04.014

No abstract available

Publication types

Comment
Letter

MeSH terms

Administration, Intranasal
Chronic Disease
Clinical Trials as Topic / methods
Humans
Ketamine / administration & dosage*
Ketamine / adverse effects*
Pain / drug therapy*
Pain / physiopathology

Substances

Ketamine